
|Articles|January 31, 2019
Eversana Reveals new Market Access Portfolio
Advertisement
Eversana, an independent provider of global services to the life sciences industry, annouced Health Strategies Insights by Eversana, a market access research and insights portfolio to help life sciences innovators make more informed decisions throughout the product lifecycle.
“The evolution of our market intelligence capabilities strengthens Eversana's growing life science platform,” said Rod Cavin, General Manager for Health Strategies Insights by Eversana. “The product portfolio provides valuable market access insights to leading global biopharmaceutical companies in various phases of product development across a number of therapeutic areas-helping our clients achieve commercial success.”
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
AbbVie to Acquire Apogee Therapeutics in $10 Billion Deal
2
Pharmaceutical Executive Daily: AbbVie Acquires Apogee Therapeutics for $10.9 Billion
3
The Benefits and Challenges of 100 Percent US-Based Manufacturing
4
Insilico Announces Collaboration with SK Biopharmaceutical for AI-Powered CNS Treatment
5



